Position in MNKD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$147,095
-$249,737 QoQ
Shares Held
60,039
-43.4% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $413,187,957 across 381 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,522 | $19,031,687 | |
| 2 | ASND |
Ascendis Pharma A/S
|
43,289 | $11,546,042 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
116,611 | $8,685,187 | |
| 4 | MRNA |
Moderna, Inc.
|
123,281 | $8,633,368 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
30,496 | $7,348,621 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
61,501 | $7,052,319 | |
| 7 | CYTK |
Cytokinetics Inc
|
80,743 | $6,878,496 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
81,923 | $6,682,459 |
All Filings in MNKD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $147,095 | 60,039 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $396,832 | 106,105 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $397,621 | 79,050 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $433,356 | 67,396 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $284,609 | 45,248 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $115,555 | 22,137 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $116,257 | 25,664 | Shares | Defined | 2024-05-13 | |
| 2023-03-31 | $43,255 | 10,550 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $91,649 | 29,660 | Shares | Defined | 2022-11-14 | |
| 2021-03-31 | $53,112 | 13,549 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||